Vijay Gayam
Overview
Explore the profile of Vijay Gayam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
778
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosado F, Taveras P, Gayam V, Narendra N, Vigoda I
Cureus
. 2023 Sep;
15(8):e42906.
PMID: 37664311
Amyloidosis is a rare group of disorders characterized by the extracellular deposition of misfolded protein aggregates that interfere with the function of the tissue affected. In some patients, the presenting...
2.
Nana Sede Mbakop R, Shah J, Forlemu A, Gayam V, Bandaru P, Kumar V, et al.
J Investig Med High Impact Case Rep
. 2023 Aug;
11:23247096231192818.
PMID: 37585743
Aortoesophageal fistula (AEF) is an uncommon, but potentially fatal cause of upper gastrointestinal bleeding. Aortoesophageal fistulas caused by foreign body ingestion are rare but devastating. The classic clinical triad of...
3.
Kanugula A, Kumar V, Gorle S, Maddika S, Kaur J, Gaduputi V, et al.
Cureus
. 2023 Jul;
15(7):e41444.
PMID: 37426399
Introduction Initially regarded as primarily a respiratory illness, coronavirus disease 2019 (COVID-19) has since been recognized as a complex disease affecting multiple systems. A COVID-19 infection can cause a hypercoagulable...
4.
Forlemu A, Nana Sede Mbakop R, Bandaru P, Gayam V, Moparty H, Sempokuya T, et al.
Int J Hepatol
. 2023 Jun;
2023:5727701.
PMID: 37292454
Background: Hepatocellular carcinoma (HCC) is a leading cause of cancer morbidity and mortality. Findings of microvascular invasion (MVI) in patients with HCC have emerged as an important prognostic factor for...
5.
Kumar V, Gala D, Wonders C, Marowa S, Forlemu A, Gayam V, et al.
Arch Clin Cases
. 2023 Apr;
10(1):50-54.
PMID: 37056950
Non-islet cell tumor hypoglycemia is an uncommon paraneoplastic phenomenon commonly associated with tumors of mesenchymal origin like gastrointestinal stromal tumors (GIST). It causes the release of insulin-like growth factor type...
6.
Gala D, Newsome T, Roberson N, Lee S, Thekkanal M, Shah M, et al.
Diseases
. 2022 Oct;
10(4).
PMID: 36278572
Inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis are chronic inflammatory disorders of the intestines. The underlying inflammation activates the coagulation cascade leading to an increased risk of developing...
7.
Abomhya A, Clemetson E, Khan F, Tageldin O, Abdulsada Z, Hamad H, et al.
J Clin Med Res
. 2022 Sep;
14(8):293-299.
PMID: 36128005
Background: Few studies evaluated the risk of acute pancreatitis (AP) in patients with Crohn's disease (CD). It's controversial if AP can be considered as an extraintestinal manifestation of CD. We...
8.
Boddhula S, Boddhula S, Garlapati P, Patel M, Ekanem S, Adapa S, et al.
Cureus
. 2022 Aug;
14(7):e26580.
PMID: 35936183
Introduction: Throughout the coronavirus disease 2019 (COVID-19) pandemic, studies have repeatedly shown that COVID-19 outcomes are more severe in the elderly and those with comorbidities, with diabetes being a significant...
9.
Subedi P, Paudel M, Gayam V, Mandal A
Cureus
. 2022 Jan;
13(12):e20186.
PMID: 35004009
Introduction Patients with inflammatory bowel diseases (IBDs) frequently develop colon cancer. Previous studies have identified the association between IBD and colon cancer. In this study, we explored the characteristics and...
10.
Patel S, Roy S, Pokal M, Gayam V, Adapa S, Patel E
J Investig Med High Impact Case Rep
. 2021 Sep;
9:23247096211045249.
PMID: 34538118
Immune checkpoint inhibitors (ICIs) are novel anticancer therapy approved in multiple tumors and their use is rapidly increasing. They are associated with various systemic side effects that are immune-mediated and...